Skip to main content
Kent Academic Repository

Pharmacists detecting atrial fibrillation (PDAF) in primary care during the influenza vaccination season: a multisite, cross-sectional screening protocol

Veale, Emma L., Stewart, Adrian J., Mathie, Alistair, Lall, Satvinder K., Rees-Roberts, Melanie, Savickas, Vilius, Bhamra, Sukvinder K., Corlett, Sarah A. (2018) Pharmacists detecting atrial fibrillation (PDAF) in primary care during the influenza vaccination season: a multisite, cross-sectional screening protocol. BMJ Open, 8 . Article Number e021121. E-ISSN 2044-6055. (doi:10.1136/bmjopen-2017-021121) (KAR id:66402)

Abstract

Introduction: Atrial fibrillation (AF) affects >6% of people aged 65 years or older. Left undetected and untreated, patients may develop significant cardiovascular complications and have a fivefold increased risk of suffering a stroke. For 40% of all sufferers, AF can be asymptomatic. Every year in the UK, £2.2 billion is spent on AF-related strokes, so there is an urgent need to improve early detection of AF. This study aims to determine the feasibility of using trained clinical pharmacists based in general practices, to screen for AF, using pulse palpation and a single-lead ECG device on participants aged 65 years or older, attending influenza vaccination clinics. Methods and analysis: Seven clinical pharmacists will be trained by a cardiologist to pulse palpate and record single-lead ECGs using the AliveCor Kardia Mobile device. Quantitative analysis will assess the accuracy and ability of the clinical pharmacist to identify pulse irregularities using pulse palpation and to record and interpret a singlelead ECG. The level of agreement of pulse irregularities detected by pulse palpation will be compared with those detected by the single-lead ECG device, as will the level of agreement between the cardiologist and the device’s interpretation of the ECG. The proportion of people identified with AF (confirmed by the cardiologist) will be determined. Additional demographic data will be obtained from all participants through a questionnaire. Qualitative data will be captured from the participants, from the clinical pharmacists and from the general practitioners and practice staff to determine their views on this method of AF screening. We aim to recruit 600 participants across general practices within Kent.

Ethics and dissemination: This protocol was approved by the London–Riverside Research Ethics committee. The findings of this study will be disseminated through forums including, but not limited to, peer-reviewed journals, national and international conferences.

Item Type: Article
DOI/Identification number: 10.1136/bmjopen-2017-021121
Uncontrolled keywords: Atrial fibrillation, AF, screening, health services research
Subjects: R Medicine > RA Public aspects of medicine > RA421 Public health. Hygiene. Preventive Medicine
R Medicine > RS Pharmacy and materia medica
Divisions: Divisions > Division of Natural Sciences > Medway School of Pharmacy
Depositing User: Emma Veale
Date Deposited: 14 Mar 2018 18:31 UTC
Last Modified: 04 Mar 2024 17:19 UTC
Resource URI: https://kar.kent.ac.uk/id/eprint/66402 (The current URI for this page, for reference purposes)

University of Kent Author Information

Veale, Emma L..

Creator's ORCID: https://orcid.org/0000-0002-6778-9929
CReDIT Contributor Roles:

Mathie, Alistair.

Creator's ORCID: https://orcid.org/0000-0001-6094-2890
CReDIT Contributor Roles:

Rees-Roberts, Melanie.

Creator's ORCID: https://orcid.org/0000-0002-7121-0414
CReDIT Contributor Roles:

Savickas, Vilius.

Creator's ORCID:
CReDIT Contributor Roles:

Bhamra, Sukvinder K..

Creator's ORCID: https://orcid.org/0000-0002-0032-0552
CReDIT Contributor Roles:

Corlett, Sarah A..

Creator's ORCID: https://orcid.org/0000-0002-8563-1527
CReDIT Contributor Roles:
  • Depositors only (login required):

Total unique views for this document in KAR since July 2020. For more details click on the image.